Trial record 1 of 1 for:    NCT01573780
Previous Study | Return to List | Next Study

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

This study has been terminated.
(Sponsor did not have funds to continue study)
Sponsor:
Collaborators:
TetraLogic Pharmaceuticals
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01573780
First received: March 13, 2012
Last updated: January 14, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)